Kadmon Prices IPO Below Range While Tactile Cuts Deal Size
Venture-backed biotech Kadmon Holdings Inc. raised $75 million in a downsized initial public offering Tuesday, while a medical technology company set to price Wednesday shed its deal size by about one...To view the full article, register now.
Already a subscriber? Click here to view full article